Pipeline

Our programs are grounded in rational science and strategies to identify API suppliers, Brand acquisition, difficulties in drug development, pivotal study requirements, Endpoint study requirements, Patent landscape and invalidation, FDA exclusivity timing, Para IV challenges, and targeted therapies that have future high value for generic applications.